107 related articles for article (PubMed ID: 10734321)
1. Demonstration in vivo that stromelysin-3 functions through its proteolytic activity.
Noël A; Boulay A; Kebers F; Kannan R; Hajitou A; Calberg-Bacq CM; Basset P; Rio MC; Foidart JM
Oncogene; 2000 Mar; 19(12):1605-12. PubMed ID: 10734321
[TBL] [Abstract][Full Text] [Related]
2. Stromelysin-3 expression promotes tumor take in nude mice.
Nöel AC; Lefebvre O; Maquoi E; VanHoorde L; Chenard MP; Mareel M; Foidart JM; Basset P; Rio MC
J Clin Invest; 1996 Apr; 97(8):1924-30. PubMed ID: 8621777
[TBL] [Abstract][Full Text] [Related]
3. Substrate specificity of Xenopus matrix metalloproteinase stromelysin-3.
Amano T; Fu L; Sahu S; Markey M; Shi YB
Int J Mol Med; 2004 Aug; 14(2):233-9. PubMed ID: 15254771
[TBL] [Abstract][Full Text] [Related]
4. Dual stromelysin-3 function during natural mouse mammary tumor virus-ras tumor progression.
Andarawewa KL; Boulay A; Masson R; Mathelin C; Stoll I; Tomasetto C; Chenard MP; Gintz M; Bellocq JP; Rio MC
Cancer Res; 2003 Sep; 63(18):5844-9. PubMed ID: 14522908
[TBL] [Abstract][Full Text] [Related]
5. Purification of active matrix metalloproteinase catalytic domains and its use for screening of specific stromelysin-3 inhibitors.
Kannan R; Ruff M; Kochins JG; Manly SP; Stoll I; El Fahime M; Noël A; Foidart JM; Rio MC; Dive V; Basset P
Protein Expr Purif; 1999 Jun; 16(1):76-83. PubMed ID: 10336863
[TBL] [Abstract][Full Text] [Related]
6. In vivo evidence that the stromelysin-3 metalloproteinase contributes in a paracrine manner to epithelial cell malignancy.
Masson R; Lefebvre O; Noël A; Fahime ME; Chenard MP; Wendling C; Kebers F; LeMeur M; Dierich A; Foidart JM; Basset P; Rio MC
J Cell Biol; 1998 Mar; 140(6):1535-41. PubMed ID: 9508784
[TBL] [Abstract][Full Text] [Related]
7. Suppression of distant pulmonary metastasis of MDA-MB 435 human breast carcinoma established in mammary fat pads of nude mice by retroviral-mediated TIMP-2 gene transfer.
Lee YK; So IS; Lee SC; Lee JH; Lee CW; Kim WM; Park MK; Lee ST; Park DY; Shin DY; Park CU; Kim YS
J Gene Med; 2005 Feb; 7(2):145-57. PubMed ID: 15546163
[TBL] [Abstract][Full Text] [Related]
8. High cancer cell death in syngeneic tumors developed in host mice deficient for the stromelysin-3 matrix metalloproteinase.
Boulay A; Masson R; Chenard MP; El Fahime M; Cassard L; Bellocq JP; Sautès-Fridman C; Basset P; Rio MC
Cancer Res; 2001 Mar; 61(5):2189-93. PubMed ID: 11280785
[TBL] [Abstract][Full Text] [Related]
9. Stromelysin-3 is a potent negative regulator of adipogenesis participating to cancer cell-adipocyte interaction/crosstalk at the tumor invasive front.
Andarawewa KL; Motrescu ER; Chenard MP; Gansmuller A; Stoll I; Tomasetto C; Rio MC
Cancer Res; 2005 Dec; 65(23):10862-71. PubMed ID: 16322233
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of the stromelysin-3 (MMP-11) catalytic domain complexed with a phosphinic inhibitor mimicking the transition-state.
Gall AL; Ruff M; Kannan R; Cuniasse P; Yiotakis A; Dive V; Rio MC; Basset P; Moras D
J Mol Biol; 2001 Mar; 307(2):577-86. PubMed ID: 11254383
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of MMP-11 (stromelysin-3) expression in mouse fibroblasts by cytokines, collagen and co-culture with human breast cancer cell lines.
Selvey S; Haupt LM; Thompson EW; Matthaei KI; Irving MG; Griffiths LR
BMC Cancer; 2004 Jul; 4():40. PubMed ID: 15272933
[TBL] [Abstract][Full Text] [Related]
12. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
[TBL] [Abstract][Full Text] [Related]
13. The matrix metalloproteinase stromelysin-3 cleaves laminin receptor at two distinct sites between the transmembrane domain and laminin binding sequence within the extracellular domain.
Amano T; Kwak O; Fu L; Marshak A; Shi YB
Cell Res; 2005 Mar; 15(3):150-9. PubMed ID: 15780176
[TBL] [Abstract][Full Text] [Related]
14. Stromelysin-3 gene expression in human cancer: an overview.
Rouyer N; Wolf C; Chenard MP; Rio MC; Chambon P; Bellocq JP; Basset P
Invasion Metastasis; 1994-1995; 14(1-6):269-75. PubMed ID: 7657519
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of matrix metalloproteinases leads to lethality in transgenic Xenopus laevis: implications for tissue-dependent functions of matrix metalloproteinases during late embryonic development.
Damjanovski S; Amano T; Li Q; Pei D; Shi YB
Dev Dyn; 2001 May; 221(1):37-47. PubMed ID: 11357192
[TBL] [Abstract][Full Text] [Related]
16. Human breast carcinoma desmoplasia is PDGF initiated.
Shao ZM; Nguyen M; Barsky SH
Oncogene; 2000 Sep; 19(38):4337-45. PubMed ID: 10980609
[TBL] [Abstract][Full Text] [Related]
17. From a unique cell to metastasis is a long way to go: clues to stromelysin-3 participation.
Rio MC
Biochimie; 2005; 87(3-4):299-306. PubMed ID: 15781316
[TBL] [Abstract][Full Text] [Related]
18. Active stromelysin-3 (MMP-11) increases MCF-7 survival in three-dimensional Matrigel culture via activation of p42/p44 MAP-kinase.
Fromigué O; Louis K; Wu E; Belhacène N; Loubat A; Shipp M; Auberger P; Mari B
Int J Cancer; 2003 Sep; 106(3):355-63. PubMed ID: 12845673
[TBL] [Abstract][Full Text] [Related]
19. Gene transfer of matrix metalloproteinase-9 induces tumor regression of breast cancer in vivo.
Bendrik C; Robertson J; Gauldie J; Dabrosin C
Cancer Res; 2008 May; 68(9):3405-12. PubMed ID: 18451168
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis.
Deryugina EI; Soroceanu L; Strongin AY
Cancer Res; 2002 Jan; 62(2):580-8. PubMed ID: 11809713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
